Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
Elisabet Viayna(Universitat de Barcelona), Diego Muñoz‐Torrero(Universitat de Barcelona), Nicolas Coquelle(Centre National de la Recherche Scientifique), Florian Nachon(Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques), Xavier Brazzolotto(Service de Santé des Armées), Israel Silman(Weizmann Institute of Science), Mattia Ricchini(Universitat de Barcelona), Jacques‐Philippe Colletier(Centre National de la Recherche Scientifique), Mégane Pons(Centre National de la Recherche Scientifique), Monika Cieslikiewicz‐Bouet(Centre National de la Recherche Scientifique), Belén Pérez(Universitat Autònoma de Barcelona), Miren Ettcheto(Biomedical Research Networking Center on Neurodegenerative Diseases), Luciano Saso(Sapienza University of Rome), Marisa Rendina(Universitat de Barcelona), Carolina A. Oliva(Pontificia Universidad Católica de Chile), Angela De Simone(University of Turin), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), Vincenza Andrisano(University of Bologna), Pierre‐Yves Renard(Centre National de la Recherche Scientifique), Ludovic Jean(Centre National de la Recherche Scientifique), Manuela Bartolini(University of Bologna), Omidreza Firuzi(Shiraz University of Medical Sciences), María L. García(Merck & Co., Inc., Rahway, NJ, USA (United States)), Elena Sánchez‐López(Instituto de Salud Carlos III), Nibaldo C. Inestrosa(Pontificia Universidad Católica de Chile), Pedro Cisternas(Pontificia Universidad Católica de Chile)
Cited by 94
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
|Journal of Biological Chemistry|2002|575